Usefulness of Automated Hematology System Sysmex XN‐3100 for the Quantification of Schistocytes and Early Detection of the Underlying Thrombotic Microangiopathy
International Journal of Laboratory Hematology · 2026-12 · 48 (6) · 1477-1485
DOI: 10.1111/ijlh.70208 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 03.08.2026. Verfasst von Marija Miloš und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia. Hauptthemen laut MEDLINE: Thrombotic Microangiopathies, Erythrocytes, Abnormal. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Introduction
Light microscopy is still the gold standard method for schistocyte counting in the blood smear. Some hematology analyzers can quantitatively determine fragmented red blood cells (FRC) as part of the full blood count. We examined the usefulness of two quantitative schistocyte methods on Sysmex XN‐3100, comparing them with the standard reference method (SCHISTO‐LM).
Methods
FRC count was performed by fluorescent flow cytometry in the reticulocyte channel. A locally designed method was applied on DI‐60 digital morphology analyzer (SCHISTO‐DI), allowing schistocyte quantification according to ICSH recommendations, using the RBC menu. FRC ≥ 1.0% and schistocytes > 2/high‐power field were considered positive. Measurements were performed in 91 blood samples/peripheral blood smears of 54 patients with a suspicion of thrombotic microangiopathy (TMA).
Results
Significantly higher FRC ( p = 0.004), SCHISTO‐DI ( p < 0.001), and SCHISTO‐LM ( p < 0.001) were found in TMA‐positive patients compared to TMA‐negative and patients in remission. Stratification of TMA‐positive patients by TMA type revealed no significant differences for all tests. Both positive SCHISTO‐LM and SCHISTO‐DI were recorded in 15/91 samples (sensitivity = 100%, 95% CI = 78.2–100.0 and negative predictive value (NPV) = 100%, 95% CI = 94.4–100.0). False‐negative FRC results were detected in 5/15 schistocyte‐positive samples (sensitivity = 66.7%, 95% CI = 38.4–88.2; NPV = 92.9%, 95% CI = 86.3–96.4). The highest agreement was revealed between SCHISTO‐DI and SCHISTO‐LM ( κ = 0.637). SCHISTO‐DI demonstrated the best AUC for discrimination between TMA‐positive and TMA‐negative patients (0.942; 95% CI = 0.843–0.987), and similar AUC (0.818; 95% CI = 0.700–0.905) as SCHISTO‐LM (0.820; 95% CI = 0.702–0.906) for discrimination between TMA‐positive and patients with TTP/aHUS in remission.
Conclusion
Despite the slightly lower sensitivity of FRC, the newly designed SCHISTO‐DI method demonstrated excellent sensitivity and NPV for schistocyte detection, concordant with SCHISTO‐LM results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
- Faculty of Pharmacy, University of Mostar, Mostar, Bosnia and Herzegovina.
- Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
- Department of Pathology and Cytology, University Hospital Centre Zagreb, Zagreb, Croatia.
- Division of Intensive Care Medicine, Department of Internal Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
- Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
ORCID-Profile: Marija Miloš, Marijana Medić, Dražen Pulanić, Désirée Coen Herak
Zitieren
APA
Miloš, M., Matković, L., Kuveždić, K. G., Ries, S., Medić, M., Pulanić, D., & Herak, D. C. (2026). Usefulness of Automated Hematology System Sysmex XN‐3100 for the Quantification of Schistocytes and Early Detection of the Underlying Thrombotic Microangiopathy. International Journal of Laboratory Hematology, 48(6), 1477-1485. https://doi.org/10.1111/ijlh.70208
Vancouver
Miloš M, Matković L, Kuveždić KG, Ries S, Medić M, Pulanić D, et al. Usefulness of Automated Hematology System Sysmex XN‐3100 for the Quantification of Schistocytes and Early Detection of the Underlying Thrombotic Microangiopathy. International Journal of Laboratory Hematology. 2026;48(6):1477-1485. doi:10.1111/ijlh.70208
BibTeX
@article{Milo2026,
author = {Miloš, Marija and Matković, Laura and Kuveždić, Koraljka Gjadrov and Ries, Sunčica and Medić, Marijana and Pulanić, Dražen and Herak, Désirée Coen},
title = {Usefulness of Automated Hematology System Sysmex XN‐3100 for the Quantification of Schistocytes and Early Detection of the Underlying Thrombotic Microangiopathy},
journal = {International Journal of Laboratory Hematology},
year = {2026},
volume = {48},
number = {6},
pages = {1477--1485},
doi = {10.1111/ijlh.70208}
}
EUVIMED